Millennium Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-608,000
Closed -$57.4M 4784
2019
Q1
$57.4M Buy
+608,000
New +$53.2M 0.09% 299
2018
Q3
Sell
-65,000
Closed -$5.16M 4568
2018
Q2
$5.16M Sell
65,000
-35,000
-35% -$2.91M 0.01% 1796
2018
Q1
$8.92M Buy
+100,000
New +$9.6M 0.01% 1415
2015
Q3
Sell
-50,000
Closed -$5.79M 4057
2015
Q2
$5.79M Sell
50,000
-800
-2% -$91.5K 0.01% 1306
2015
Q1
$5.86M Buy
+50,800
New +$6.07M 0.01% 1327
2014
Q3
Sell
-11,800
Closed -$1.01M 4365
2014
Q2
$1.01M Buy
+11,800
New +$897K ﹤0.01% 2193
2014
Q1
Sell
-5,200
Closed -$439K 4310
2013
Q4
$439K Buy
+5,200
New +$411K ﹤0.01% 2797

Other funds holding CELG

Millennium Management's CELG Position: Q4 2019 in Review

Millennium Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,169,794 shares — an estimated $414M sold.

Millennium Management first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $414M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Millennium Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Millennium Management sold 4,169,794 Celgene Corp shares in Q4 2019, an estimated $414M.
  • Millennium Management first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Millennium Management's Celgene Corp position peaked at $414M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.